Keyphrases
Cyclin-dependent Kinase 9 (CDK9)
100%
Cancer Stem-like
100%
Triple-negative Breast Cancer
100%
Antineoplastic Agents
100%
Atuveciclib
100%
Breast
25%
Mammosphere
25%
Pharmacological Inhibitors
12%
Overall Survival
12%
Cell Proliferation
12%
Reduced Expression
12%
Cancer Genome Atlas
12%
Therapy Resistance
12%
Inhibitory Effect
12%
Targeted Therapy
12%
Putative Drug Targets
12%
Breast Cancer Patients
12%
Treatment Options
12%
Cluster of Differentiation 44 (CD44)
12%
Tumor Recurrence
12%
Metastatic Potential
12%
Metastatic Disease
12%
Cell Survival
12%
Cisplatin
12%
Tumor Therapy
12%
Small Populations
12%
Recurrent Disease
12%
Atlas Data
12%
Breast Cancer Cell Lines
12%
Triple-negative Breast Cancer Cells
12%
Invasion Potential
12%
Myeloid Cell leukemia-1 (Mcl-1)
12%
CD24
12%
Tumorsphere
12%
3D Invasion
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin Dependent Kinase 9
100%
Malignant Neoplasm
100%
Anticarcinogen
100%
Triple Negative Breast Cancer
100%
Atuveciclib
100%
Cisplatin
12%
Metastasis
12%
Overall Survival
12%
Breast Cancer
12%
Therapy Resistance
12%
Recurrent Disease
12%
Metastasis Potential
12%
Tumor Recurrence
12%
Biochemistry, Genetics and Molecular Biology
Cyclin-Dependent Kinase 9
100%
MCL1
12%
Cancer Cell
12%
Cell Proliferation
12%
CD44
12%
Cisplatin
12%
Cell Survival
12%
Overall Survival
12%
CD24
12%